Literature DB >> 2955635

Fatal aplastic anemia in a child with Down's syndrome.

A Hanukoglu, D Meytes, A Fried, N Rosen, N Shacked.   

Abstract

An infant with Down's syndrome developed severe persistent neutropenia at the age of 9 months and fluctuating anemia and thrombocytopenia at one year of age which terminated as full-blown aplastic anemia at 26 months of age. Immunological evaluation revealed increased peripheral and bone marrow lymphocytes and impaired blood OKT4: OKT8 ratio. Bone marrow granulocyte-macrophage colony forming cells (GM-CFC) were markedly increased, while peripheral blood mononuclear cells (PBMN) produced normal numbers of colonies. The patient's PBMN and serum were both somewhat inhibitory to normal bone marrow derived GM-CFC, suggesting the existence of a suppressor activity both in his serum and PBMN. This unusual course of aplastic anemia and the abnormalities in T-cells and hematopoiesis in Down's syndrome are discussed.

Entities:  

Mesh:

Year:  1987        PMID: 2955635     DOI: 10.1111/j.1651-2227.1987.tb10515.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  5 in total

1.  Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.

Authors:  S Raziuddin; M E Elawad
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

2.  Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.

Authors:  Kyogo Suzuki; Hideki Muramatsu; Yusuke Okuno; Atsushi Narita; Asahito Hama; Yoshiyuki Takahashi; Makoto Yoshida; Yasuo Horikoshi; Ken-Ichiro Watanabe; Kazuko Kudo; Seiji Kojima
Journal:  Int J Hematol       Date:  2016-04-23       Impact factor: 2.490

3.  Captopril-induced bone marrow suppression in two cardiac patients with trisomy 21.

Authors:  M M Gleason; J S Roloff; S E Cyran; H S Weber; B G Baylen; J L Myers
Journal:  Pediatr Cardiol       Date:  1993-10       Impact factor: 1.655

4.  Epstein-Barr virus-related post-transplant lymphoproliferative disorder occurring after bone marrow transplantation for aplastic anemia in Down's syndrome.

Authors:  Aya Furuya; Mitsuaki Ishida; Keiko Hodohara; Miyuki Yoshii; Hiroko Okuno; Akiko Horinouchi; Ryota Nakanishi; Ayumi Harada; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Takashi Yoshida; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

5.  An epidemiological study on anemia among institutionalized people with intellectual and/or motor disability with special reference to its frequency, severity and predictors.

Authors:  Hiroko Ohwada; Takeo Nakayama; Nobuo Nara; Yuji Tomono; Keiko Yamanaka
Journal:  BMC Public Health       Date:  2006-04-03       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.